The mechanical milieu in which cells reside plays a crucial role in regulating their physiological behavior. Native tissue matrices exhibit complex mechanical properties, including viscoelasticity and nonlinear elasticity, which are essential not only for maintaining cellular health but also for directing differentiation and repair. However, aging and disease progressively degrade these mechanical characteristics, contributing to tissue dysfunction and pathologies such as neurodegeneration and cancer. Despite the recognized importance of mechanical cues, prior biomaterial platforms have largely failed to replicate the intricate viscoelastic and nonlinear elastic behavior of living tissues simultaneously, limiting our capacity to interrogate and manipulate cell mechanobiology effectively.

Addressing this critical gap, Professor Yiwei Li and Professor Bi-Feng Liu’s team have engineered an interpenetrating network (IPN) hydrogel composed of alginate and collagen, designed meticulously to mimic the native mechanical environment of soft tissues. This composite hydrogel synergizes collagen’s nonlinear elasticity with alginate’s viscoelastic shear-thinning properties, thereby creating a matrix that faithfully recapitulates the dual mechanical nature of biological tissues. The researchers demonstrated the ability to fine-tune the hydrogel’s initial stiffness via calcium ion crosslinking adjustments without altering the biochemical composition, enabling precise simulation of tissue mechanics across different physiological and pathological states.

A striking observation emerged when fibroblasts were cultured on this tissue-mimicking hydrogel. The cells initially spread on the surface but soon began migrating towards each other, coalescing into mesenchymal aggregates—a behavior absent on matrices comprising only collagen or alginate. This aggregation coincided with significant remodeling of collagen fibers into bundled structures, implying an active matrix-cell mechanical feedback mechanism. Such cell–matrix mechanical crosstalk facilitates long-range cellular interactions transmitted through the remodeled extracellular matrix, revealing novel insights into how collective cell behavior can be directed by the physical microenvironment.

Critical to this phenomenon is cellular contractility, as elucidated by experiments employing contractility inhibitors. When contractile forces were suppressed, mesenchymal aggregates dissipated into lone cells, accompanied by a marked downregulation of reprogramming-associated gene expression and loss of enhanced differentiation capacity. This underscores a positive feedback loop where matrix mechanics enhance cell contractility, which in turn drives reprogramming signals. The feedback mechanism creates a self-reinforcing cycle fundamental for driving the observed cellular phenotypic shifts.

Transcriptomic profiling further validated the profound reprogramming effects induced by the engineered hydrogel. Stemness-associated genes, notably markers emblematic of mesenchymal stem cells such as Id1, Id2, Cd36, and Cd9, were significantly upregulated within these aggregates. Concurrently, key signaling pathways implicated in cell fate determination—including Wnt, Hippo, and PPAR pathways—were robustly activated. Intriguingly, the traditional antagonism between adipogenic and osteogenic differentiation pathways was resolved, with genes corresponding to both lineages being simultaneously elevated, illustrating a nuanced and flexible cellular differentiation landscape fostered by mechanical cues.

Functional assays corroborated these findings, revealing that fibroblasts cultured on the hydrogel exhibited substantially increased lipid droplet accumulation upon adipogenic induction—at 2.5 times the level observed on standard matrices—and pronounced alkaline phosphatase (ALP) expression following osteogenic stimulation. These findings not only confirm the hydrogel’s role in promoting bidirectional differentiation potential but also highlight its utility as a versatile platform for stem cell modulation without biochemical additives.

Extending these discoveries to oncological applications, the team demonstrated that non-small cell lung cancer H1975 cells cultured within the tissue-mimicking hydrogel underwent transdifferentiation into adipocyte-like cells. Morphologically, the cancer cells shifted from a spread mesenchymal phenotype to aggregate formation, coupled with cortical actin reorganization indicative of reduced migratory potential. They expressed hallmark adipogenic markers such as Perilipin and PPARγ, confirming successful lineage conversion. This mechanical reprogramming effectively immobilizes cancer cells by inducing a less proliferative and more differentiated state.

Molecular analysis of cancer cells post-transdifferentiation revealed profound transcriptomic alterations. Genes driving epithelial-mesenchymal transition (EMT), a key contributor to metastasis and malignancy, were suppressed, whilst genes facilitating mesenchymal-epithelial transition (MET) were activated, suggesting a reversion to a more epithelial, less invasive phenotype. Oncogenes including EGFR, BRCA1, and CDC20 were downregulated, while tumor suppressor genes such as ACSL1, GADD45G, and CRB3 were upregulated, indicating a reversal of malignant characteristics. These comprehensive molecular shifts highlight the capacity of mechanical cues delivered by the hydrogel to reprogram cancer cells towards a less aggressive, therapy-sensitive state.

The clinical implications of this mechanical reprogramming approach are both vast and profound. Beyond its promise as a platform for ex vivo expansion and enhancement of autologous stem cells in regenerative medicine, the hydrogel system can be further translated into injectable scaffolds that facilitate in situ tissue repair by promoting aggregation and differentiation of endogenous or transplanted cells. In cancer treatment paradigms, this method offers a disruptive shift—transforming proliferative cancer cells into differentiated, non-proliferative adipocytes could attenuate tumor progression and complement existing chemotherapy and radiotherapy modalities, potentially mitigating drug resistance and relapse.

This mechanically driven reprogramming approach also addresses key limitations inherent in conventional methods. By sidestepping genetic modification and biochemical cocktails, it substantially reduces risks associated with off-target gene effects and tumorigenicity, while providing a stable physical niche that sustains reprogramming signals over extended durations. Its applicability across diverse cell types enhances the versatility of this platform, and its mimicry of native tissue mechanics offers a more physiologically relevant environment for drug screening, enabling precise evaluation of candidate compounds and their effects on cell fate within a biomimetic matrix.

In summary, the work led by Professors Yiwei Li and Bi-Feng Liu represents a landmark achievement in bioengineering and mechanobiology. By elucidating the essential interplay between matrix viscoelasticity, nonlinear elasticity, and cellular contractility, the study unveils a previously uncharted mechanism of long-range mechanical cell–cell interactions that drive potent reprogramming effects. This insight not only advances fundamental understanding of cell microenvironmental regulation but also propels the development of innovative therapeutic strategies aimed at addressing global challenges such as aging-related tissue degeneration and refractory cancers.

As this technology moves towards clinical translation, further refinement and optimization of hydrogel properties and delivery strategies will be pivotal. However, the promise it holds—as a novel, mechanically oriented, and safe means to manipulate cell behavior—positions it at the forefront of future biomedical innovation. The convergence of materials science, cell biology, and clinical medicine embodied by this hydrogel platform heralds a new chapter in harnessing the power of physical forces for human health.

Subject of Research: Not applicable

Article Title: Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogels for Cancer Cell Transdifferentiation

News Publication Date: 18-Aug-2025

Web References: http://dx.doi.org/10.34133/research.0810

Image Credits: Copyright © 2025 Xueqing Ren et al.

Keywords: Tissue-mimicking hydrogel, mechanical cell reprogramming, viscoelasticity, nonlinear elasticity, fibroblast differentiation, cancer transdifferentiation, mechanobiology, extracellular matrix remodeling, cell contractility, regenerative medicine, adipogenesis, osteogenesis, cell aggregation

This innovative system, known as self-assembling boronate ester release or SABER, implements a sophisticated structure for drug delivery. By utilizing peptide-based hydrogels, the team has crafted a three-dimensional net capable of controlling the rate of drug release. The unique aspect of SABER lies in its employment of reversible chemical bonds between the peptide in the hydrogel and a specific chemical group on the drug molecule. While the system enables prolonged drug release, patients benefit from consistent therapeutic levels over time, reducing the burdens associated with frequent dosing.

In an impressive display of the system’s capabilities, the Rice team tested SABER with a tuberculosis medication in infected mice. The results were compelling. A singular injection of the drug-laden hydrogel proved to outshine nearly daily oral dosing over the span of two weeks. This finding alone illustrates the potential this new pharmaceutical technology has in significantly improving treatment efficiency and patient convenience. Similarly, experiments utilizing insulin demonstrated that SABER also offers continuous blood sugar regulation for diabetic mice, showcasing its versatility. Controlled insulin release lasted an astonishing six days, in stark contrast to the mere four hours provided by conventional administration methods.

SABER’s ability to exhibit a prolonged release of medication represents a critical advancement, particularly in the domain of highly time-sensitive treatments, such as insulin therapy for diabetes and anti-tuberculosis medications for patients in resource-limited settings. The major concern with conventional methods lies in patients’ difficulties with adherence to complicated treatment regimens, which can lead to suboptimal outcomes. By creating a system that simplifies dosing and enhances drug effectiveness, SABER stands as a solution to improving patient adherence—especially for chronic diseases requiring sustained medication intake over extended periods.

Brett Pogostin, the lead author of the study and a Ph.D. graduate from Rice, played a pivotal role in the development of the SABER platform. His interdisciplinary background in chemistry and bioengineering has been instrumental in bridging fundamental research with significant medical applications. As an undergraduate, Pogostin began exploring self-assembling peptides, which later became the foundation of his work in drug delivery mechanisms. His dedication and innovative mindset have not only advanced research at Rice but also contributed to tangible solutions for pressing health issues.

The inspiration for the SABER concept arose during Pogostin’s studies on dynamic covalent bonds utilized in glucose sensing during a drug delivery course. Learning about these bonds, which can reversibly form and break apart, sparked an idea in him to adapt this mechanism for a hydrophilic environment like hydrogels, leading to a major breakthrough in the patient-friendly administration of pharmaceuticals. The fundamental challenge addressed in this work is the rapid release of small drugs from conventional hydrogels, akin to trying to catch small fish with a net designed for larger species. By advancing this design into one that is “sticky,” the researchers could finetune release rates based on the temporary binding of drugs, thereby enhancing treatment outcomes.

To confirm the efficacy of SABER, the team executed rigorous experiments involving mouse models that are critical in drug development stages. Tuberculosis is known as a global health scourge, and the findings related to enhanced drug release promise to address the prevailing issues of access and adherence found predominantly in low-resource environments. Similarly, the hydrogel’s applicability for insulin delivery showcases a thoughtful approach to addressing the frustration faced by Type 1 diabetic patients who strive for consistent and effective blood sugar management.

The environmental friendliness of the SABER platform cannot go unnoticed. Since the hydrogel is composed of amino acids, it can break down naturally inside the body, forming a temporary structure that dissolves without producing harmful byproducts. This biocompatibility greatly enhances the utility of the platform as researchers worldwide strive to develop drug delivery methods that not only meet efficacy benchmarks but also prioritize patient safety.

Development from concept to the realization of the SABER platform necessitated a high degree of interdisciplinary cooperation. Collaboration extended beyond Rice, involving chemists who provided insights related to boronic acid interactions and experts from Johns Hopkins University who recognized tuberculosis as an essential application area. Researchers also faced various challenges, from custom measuring techniques for drug concentration in animal studies to optimization issues that required creative solutions. Such a diverse array of expertise and shared innovation exemplifies how collaborative efforts can drive significant advancements in scientific research.

As the research community continues to explore and refine the SABER platform, the implications for future medical applications are abundant. Both Hartgerink and McHugh, co-authors on the paper, emphasize the vast potential of SABER in areas such as cancer immunotherapy by controlling the timing and delivery of therapeutic agents—thereby minimizing adverse side effects commonly associated with conventional cancer treatments.

Moving forward, both Pogostin, who is now a postdoctoral fellow with noteworthy aspirations in cancer prevention research, and his collaborators aim to elevate the functionalities of the SABER system to enhance its real-world applications further. Their vision is to utilize advanced materials to prepare the immune system against cancer proactively, representing a paradigm shift in how we understand treatment methodologies.

This novel approach, bridging chemistry and bioengineering with innovative problem-solving strategies, holds the potential to improve not only the administration of existing drugs but also how new therapies are developed and delivered. Each advancement in drug delivery systems like SABER serves to illustrate the dynamic and ever-evolving landscape of healthcare innovation, laying the groundwork for more effective, efficient, and patient-centered medical treatments.

With research endeavors continuously supported by well-established institutions such as the National Science Foundation and the National Institutes of Health, the future of drug delivery systems remains promising. The aim is to not only develop targeted therapies but to ensure that they operate within frameworks that improve treatment experiences for patients globally. The breadth of this research underscores a commitment to impacting public health profoundly and positively, resonating with aspirational goals across the healthcare spectrum.

Subject of Research: Drug Delivery Systems
Article Title: Nanofibrous supramolecular peptide hydrogels for controlled release of small molecule drugs and biologics
News Publication Date: 10-Sep-2025
Web References: Nature Nanotechnology
References: N/A
Image Credits: Photo by Gustavo Raskosky/Rice University

Keywords

Drug delivery, hydrogels, insulin, tuberculosis, peptide technology, patient adherence, therapeutic regimens, chronic disease management, biocompatibility, interdisciplinary collaboration, cancer immunotherapy, molecular engineering.